CardioVision registers two stepped-wedge trials for TORCH transplant pathways in Latin America
Both studies, not yet recruiting, will test regional referral and candidacy pathways for adult and congenital heart disease patients across Latin American transplant networks.
CardioVision International Tech registered two related health-services trials on 2026-09-23, both not yet recruiting and estimated to begin 2027-03-30.
- NCT07836803 (TORCH-LATAM-002) is a stepped-wedge cluster randomized trial evaluating an integrated regional pathway for adults with advanced heart failure who require specialized heart transplant evaluation and a documented candidacy decision.1 The primary outcome is completion of multidisciplinary evaluation and a documented transplant-candidacy decision within 90 days after enrollment,1 with estimated enrollment of 360 participants.
- NCT07837024 (TORCH-LATAM-003) is a companion stepped-wedge trial evaluating a regional pathway for children and adults with congenital heart disease and advanced cardiac and/or respiratory failure who may require heart, lung, or heart-lung transplantation, mechanical circulatory or extracorporeal support, or another regulated advanced-therapy pathway.2 Its primary outcome is completion of the prespecified multidisciplinary evaluation and documentation of an advanced-pathway decision within 90 days after enrollment,2 also with an estimated 360 participants.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.